# Jones Lang Lasalle Inc: overview

JLL · NYSE · CIK 1037976 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jll.md) · [Financials](/companies/jll/financials.md) · [Filings](/companies/jll/filings.md) · [Insiders](/companies/jll/insiders.md)

Latest reported revenue: [$7.28bn](/filings/0001037976-26-000189.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 28, 2026 (XBRL us-gaap:Revenues, accession 0001037976-26-000189).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,811 d](/filings/0001037976-26-000037.md) | [5,746](/filings/0001037976-26-000106.md) | [6,250](/filings/0001037976-26-000152.md) | [6,510](/filings/0001037976-26-000189.md) | [7,609 d](/filings/0001037976-26-000037.md) | [6,387](/filings/0001037976-26-000106.md) | [6,928](/filings/0001037976-26-000152.md) | [7,281](/filings/0001037976-26-000189.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [5.5% d](/filings/0001037976-26-000037.md) | [2.1%](/filings/0001037976-26-000106.md) | [3.2%](/filings/0001037976-26-000152.md) | [4.2%](/filings/0001037976-26-000189.md) | [6.7% d](/filings/0001037976-26-000037.md) | [3.2%](/filings/0001037976-26-000106.md) | [4.2%](/filings/0001037976-26-000152.md) | [5.4%](/filings/0001037976-26-000189.md) |
| Net margin | % | [3.5% d](/filings/0001037976-26-000037.md) | [1.0%](/filings/0001037976-26-000106.md) | [1.8%](/filings/0001037976-26-000152.md) | [3.4%](/filings/0001037976-26-000189.md) | [5.3% d](/filings/0001037976-26-000037.md) | [2.5%](/filings/0001037976-26-000106.md) | [3.1%](/filings/0001037976-26-000152.md) | [4.4%](/filings/0001037976-26-000189.md) |
| Diluted EPS | $ per share | not reported | [1.14](/filings/0001037976-26-000106.md) | [2.32](/filings/0001037976-26-000152.md) | [4.61](/filings/0001037976-26-000189.md) | not reported | [3.33](/filings/0001037976-26-000106.md) | [4.59](/filings/0001037976-26-000152.md) | [6.85](/filings/0001037976-26-000189.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [19.4](/filings/0001037976-24-000010.md) | [20.9](/filings/0001037976-25-000006.md) | [20.8](/filings/0001037976-26-000037.md) | [23.4](/filings/0001037976-26-000037.md) | [26.1](/filings/0001037976-26-000037.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [5.4%](/filings/0001037976-24-000010.md) | [4.2%](/filings/0001037976-25-000006.md) | [2.8%](/filings/0001037976-26-000037.md) | [3.7%](/filings/0001037976-26-000037.md) | [4.2%](/filings/0001037976-26-000037.md) |
| Net margin | % | [5.0%](/filings/0001037976-24-000010.md) | [3.1%](/filings/0001037976-25-000006.md) | [1.1%](/filings/0001037976-26-000037.md) | [2.3%](/filings/0001037976-26-000037.md) | [3.0%](/filings/0001037976-26-000037.md) |
| Diluted EPS | $ per share | [18.47](/filings/0001037976-24-000010.md) | [13.27](/filings/0001037976-25-000006.md) | [4.67](/filings/0001037976-26-000037.md) | [11.30](/filings/0001037976-26-000037.md) | [16.40](/filings/0001037976-26-000037.md) |
| Free cash flow | $bn | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/jll/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.45bn | 4,666,603 |  | Added +23,839 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.34bn | 4,337,327 |  | Reduced −10,943 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $966.2m | 3,117,154 |  | Added +423,642 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $650.3m | 2,098,037 |  | Reduced −8,947 |
| [EdgePoint Investment Group Inc.](/funds/1481669.md) | 2026-06-30 | $566.8m | 1,828,591 |  | Reduced −76,420 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $459.9m | 1,483,938 |  | Added +27,073 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $457.5m | 1,475,893 |  | Reduced −188,793 |
| [ARIEL INVESTMENTS, LLC](/funds/936753.md) | 2026-06-30 | $328.6m | 1,060,265 |  | Added +35,988 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $310.2m | 1,000,519 |  | Reduced −23,633 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $283.1m | 913,321 |  | Added +59,379 |

## Recent filings

[All 1,834 filings](/companies/jll/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 07:56 ET | [8-K](/filings/0001037976-26-000191.md) | 8.01 Other events | 0001037976-26-000191 |
| 2026-10-28 | 13:41 ET | [10-Q](/filings/0001037976-26-000189.md) | Quarterly report, period 2026-09-30 | 0001037976-26-000189 |
| 2026-10-28 | 07:33 ET | [8-K](/filings/0001037976-26-000187.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001037976-26-000187 |
| 2026-09-30 | 16:45 ET | [8-K](/filings/0001037976-26-000173.md) | 5.02 Departure or appointment of officers or directors | 0001037976-26-000173 |
| 2026-09-16 | 08:25 ET | [8-K](/filings/0001037976-26-000167.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001037976-26-000167 |
| 2026-07-30 | 13:45 ET | [10-Q](/filings/0001037976-26-000152.md) | Quarterly report, period 2026-06-30 | 0001037976-26-000152 |
| 2026-07-30 | 07:31 ET | [8-K](/filings/0001037976-26-000150.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001037976-26-000150 |
| 2026-05-28 | 14:23 ET | [8-K](/filings/0001037976-26-000108.md) | 5.07 Shareholder vote results | 0001037976-26-000108 |
| 2026-04-30 | 13:49 ET | [10-Q](/filings/0001037976-26-000106.md) | Quarterly report, period 2026-03-31 | 0001037976-26-000106 |
| 2026-04-30 | 07:31 ET | [8-K](/filings/0001037976-26-000104.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001037976-26-000104 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001037976-26-000037.md), filed Feb 19, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/9f303fe5-3801-4ddf-89fb-e8af02505471)

## About the filer

- CIK: 1037976
- Tickers: JLL
- Exchange: NYSE
- SIC code: 6531 Real Estate Agents & Managers (For Others)
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 31, 2026, 03:04 ET. No prices; not investment advice.